Table: Rohto - 9-MTH group results

Rohto Pharmaceutical

13/02/2019 06:00

Feb 13 (Reuters)- 
             Rohto Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   9 months ended      9 months ended       Year to 
                  Dec 31, 2018        Dec 31, 2017     Mar 31, 2019 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales              134.70              124.11           183.30    
                   (+8.5 pct)          (+11.4 pct)      (+6.7 pct)  
  Operating           17.19               15.61            21.40    
                   (+10.2 pct)         (+25.9 pct)      (+12.1 pct) 
  Recurring           17.62               15.75            21.80    
                   (+11.9 pct)         (+21.5 pct)      (+15.7 pct) 
  Net                 10.87               10.10            13.30    
                   (+7.6 pct)          (+20.1 pct)      (+43.2 pct) 
  EPS               95.40 yen           88.68 yen       116.70 yen  
  EPS Diluted       95.03 yen           88.31 yen                   
  Ann Div                               22.00 yen        25.00 yen  
  -Q2 div           11.00 yen           11.00 yen                   
  -Q4 div                               11.00 yen        14.00 yen  
  
  NOTE - Rohto Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4527.T